Answers are grounded in this paper and cite their sources.
Prostaglandin E1 (PGE1) and platelet activation factor (PAF) were found respectively to activate or to inhibit cholesterol esterification in whole plasma but not in lipoprotein-deficient plasma. It is suggested that these effects are mediated by the interaction of PGE1 and PAF with high-density lipoproteins [(1984) FEBS Lett. 173, 291-294]. Possible physiological implications of these findings are discussed.
No takes yet. Share an insight, caveat, or question.
Bergel'son et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: